Ozempic and Multiple Sclerosis: Insights From Dr. Aaron Boster on GLP-1 Agonists
Ozempic (a brand name for semaglutide) and similar drugs are all over the news. They were even named 2023’s “breakthrough ...
Continue with Facebook
Sign up with your email
Become a member to get even more